Search by Drug Name or NDC

    NDC 59627-0002-06 Avonex 30 ug/.5mL Details

    Avonex 30 ug/.5mL

    Avonex is a INTRAMUSCULAR INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Biogen Inc.. The primary component is INTERFERON BETA-1A.

    Product Information

    NDC 59627-0002
    Product ID 59627-002_3ff19956-a793-4256-bff4-7f7443d7238a
    Associated GPIs
    GCN Sequence Number 053430
    GCN Sequence Number Description interferon beta-1a SYRINGE 30MCG/.5ML INTRAMUSC
    HIC3 H0E
    HIC3 Description AGENTS TO TREAT MULTIPLE SCLEROSIS
    GCN 20908
    HICL Sequence Number 011253
    HICL Sequence Number Description INTERFERON BETA-1A
    Brand/Generic Brand
    Proprietary Name Avonex
    Proprietary Name Suffix n/a
    Non-Proprietary Name Interferon Beta-1a
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR
    Active Ingredient Strength 30
    Active Ingredient Units ug/.5mL
    Substance Name INTERFERON BETA-1A
    Labeler Name Biogen Inc.
    Pharmaceutical Class Interferon beta [EPC], Interferon-beta [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA103628
    Listing Certified Through 2024-12-31

    Package

    NDC 59627-0002-06 (59627000206)

    NDC Package Code 59627-002-06
    Billing NDC 59627000206
    Package 1 TRAY in 1 CARTON (59627-002-06) / 1 SYRINGE in 1 TRAY (59627-002-07) / .5 mL in 1 SYRINGE
    Marketing Start Date 2003-05-23
    NDC Exclude Flag N
    Pricing Information N/A